简体中文
EnglishWhat Safety Information Should I Know Before Getting Synvisc-One?
Updated
Before considering Synvisc-One, the most important safety step is telling your doctor if you have ever had an allergic reaction to SYNVISC, Synvisc-One, or any hyaluronan-based product. According to the official site, warning signs of such a reaction include swelling of the face, tongue, or throat; respiratory difficulty; rash; itching; or hives. This information applies to U.S. residents, and it does not replace advice from your healthcare professional.
The Allergic-Reaction Warning Signs to Watch For
The Synvisc-One official site lists specific signs that may indicate an allergic reaction. You should be aware of these before treatment and know what to report:
- Swelling of the face, tongue, or throat
- Respiratory difficulty
- Rash
- Itching
- Hives
These are the reactions the site specifically names in its Important Safety Information. If you have experienced any of these after a prior injection or exposure to a hyaluronan-based product, that history is exactly what your doctor needs to know.
What to Tell Your Doctor Before Treatment
The site's guidance centers on one key disclosure: prior allergic reactions. Before trying Synvisc-One or SYNVISC, tell your doctor if you have had an allergic reaction — such as the signs listed above — to SYNVISC, Synvisc-One, or any hyaluronan-based products.
This matters because your medical history shapes whether an injectable treatment is appropriate for you. The site does not provide a full checklist of every condition to disclose, so the practical approach is to share your complete allergy and treatment history with your doctor rather than relying on the website alone.
Where to Find the Full Safety Details
The official site points readers to two documents for complete information:
| Resource | What it covers |
|---|---|
| Important Safety Information | The safety warnings summarized on the site |
| Prescribing Information | The full prescribing details for healthcare professionals |
Both are available on synviscone.com. The site also separates content for patients and healthcare professionals, so make sure you are reading the patient-facing materials if you are researching for yourself.
What Synvisc-One Is Indicated For
Understanding the safety information also means understanding who the treatment is intended for. According to the site, SYNVISC (hylan G-F 20) and SYNVISC-ONE (hylan G-F 20) are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, such as acetaminophen.
In other words, it is not positioned as a first-line option. If you have not yet tried conservative approaches and simple pain relievers, that context is part of the conversation with your doctor.
Important Limits of This Information
The site states it is for U.S. residents only. It provides general safety information and links to the Prescribing Information, but it is not a substitute for professional medical advice. Your doctor can assess your individual history, including any prior reactions, and determine whether Synvisc-One is appropriate for you.
If you want to review the details yourself before an appointment, the Important Safety Information and Prescribing Information on the official site are the starting points — then bring your questions to your healthcare professional.